Cargando…
Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors
PURPOSE: The purpose of this retrospective study was to identify the independent prognostic factors and optimize the treatment for nasopharyngeal carcinoma (NPC) patients with distant metastasis at initial diagnosis. METHODS: A total of 234 patients referred between January 2001 and December 2010 we...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172685/ https://www.ncbi.nlm.nih.gov/pubmed/25247415 http://dx.doi.org/10.1371/journal.pone.0108070 |
_version_ | 1782336058066731008 |
---|---|
author | Zeng, Lei Tian, Yun-Ming Huang, Ying Sun, Xue-Ming Wang, Feng-Hua Deng, Xiao-Wu Han, Fei Lu, Tai-Xiang |
author_facet | Zeng, Lei Tian, Yun-Ming Huang, Ying Sun, Xue-Ming Wang, Feng-Hua Deng, Xiao-Wu Han, Fei Lu, Tai-Xiang |
author_sort | Zeng, Lei |
collection | PubMed |
description | PURPOSE: The purpose of this retrospective study was to identify the independent prognostic factors and optimize the treatment for nasopharyngeal carcinoma (NPC) patients with distant metastasis at initial diagnosis. METHODS: A total of 234 patients referred between January 2001 and December 2010 were retrospectively analyzed. Among the 234 patients, 94 patients received chemotherapy alone (CT), and 140 patients received chemoradiotherapy (CRT). Clinical features, laboratory parameters and treatment modality were examined with univariate and multivariate analyses. RESULTS: The median overall survival (OS) time was 22 months (range, 2-125 months), and the 1-year, 2-year, 3-year overall survival rates were 82.2%, 51.3% and 34.1%. The overall response and disease control rates of metastatic lesions after chemotherapy were 56.0% and 89.8%. The factors associated with poor response were karnofsky performance score (KPS) <80, liver metastasis, lactate dehydrogenase (LDH)>245 IU/L, and number of chemotherapy cycles <4. The 3-year OS of patients receiving CRT was higher than those receiving CT alone (48.2% vs. 12.4%, p<0.001). Subgroup analysis showed that significantly improved survival was also achieved by radiotherapy of the primary tumor in patients who achieved complete remission (CR)/partial remission (PR) or stable disease (SD) of metastatic lesions after chemotherapy. Significant independent prognostic factors of OS were KPS, liver metastasis, levels of LDH, and multiple metastases. Treatment modality, response to chemotherapy and chemotherapy cycles were also associated with OS. CONCLUSION: A combination of radiotherapy and chemotherapy seems to have survival benefits for selected patients with distant metastases at initial diagnosis. Clinical and laboratory characteristics can help to guide treatment selection. Prospective randomized studies are needed to confirm the result. |
format | Online Article Text |
id | pubmed-4172685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41726852014-10-02 Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors Zeng, Lei Tian, Yun-Ming Huang, Ying Sun, Xue-Ming Wang, Feng-Hua Deng, Xiao-Wu Han, Fei Lu, Tai-Xiang PLoS One Research Article PURPOSE: The purpose of this retrospective study was to identify the independent prognostic factors and optimize the treatment for nasopharyngeal carcinoma (NPC) patients with distant metastasis at initial diagnosis. METHODS: A total of 234 patients referred between January 2001 and December 2010 were retrospectively analyzed. Among the 234 patients, 94 patients received chemotherapy alone (CT), and 140 patients received chemoradiotherapy (CRT). Clinical features, laboratory parameters and treatment modality were examined with univariate and multivariate analyses. RESULTS: The median overall survival (OS) time was 22 months (range, 2-125 months), and the 1-year, 2-year, 3-year overall survival rates were 82.2%, 51.3% and 34.1%. The overall response and disease control rates of metastatic lesions after chemotherapy were 56.0% and 89.8%. The factors associated with poor response were karnofsky performance score (KPS) <80, liver metastasis, lactate dehydrogenase (LDH)>245 IU/L, and number of chemotherapy cycles <4. The 3-year OS of patients receiving CRT was higher than those receiving CT alone (48.2% vs. 12.4%, p<0.001). Subgroup analysis showed that significantly improved survival was also achieved by radiotherapy of the primary tumor in patients who achieved complete remission (CR)/partial remission (PR) or stable disease (SD) of metastatic lesions after chemotherapy. Significant independent prognostic factors of OS were KPS, liver metastasis, levels of LDH, and multiple metastases. Treatment modality, response to chemotherapy and chemotherapy cycles were also associated with OS. CONCLUSION: A combination of radiotherapy and chemotherapy seems to have survival benefits for selected patients with distant metastases at initial diagnosis. Clinical and laboratory characteristics can help to guide treatment selection. Prospective randomized studies are needed to confirm the result. Public Library of Science 2014-09-23 /pmc/articles/PMC4172685/ /pubmed/25247415 http://dx.doi.org/10.1371/journal.pone.0108070 Text en © 2014 Zeng et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Zeng, Lei Tian, Yun-Ming Huang, Ying Sun, Xue-Ming Wang, Feng-Hua Deng, Xiao-Wu Han, Fei Lu, Tai-Xiang Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors |
title | Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors |
title_full | Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors |
title_fullStr | Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors |
title_full_unstemmed | Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors |
title_short | Retrospective Analysis of 234 Nasopharyngeal Carcinoma Patients with Distant Metastasis at Initial Diagnosis: Therapeutic Approaches and Prognostic Factors |
title_sort | retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172685/ https://www.ncbi.nlm.nih.gov/pubmed/25247415 http://dx.doi.org/10.1371/journal.pone.0108070 |
work_keys_str_mv | AT zenglei retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors AT tianyunming retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors AT huangying retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors AT sunxueming retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors AT wangfenghua retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors AT dengxiaowu retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors AT hanfei retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors AT lutaixiang retrospectiveanalysisof234nasopharyngealcarcinomapatientswithdistantmetastasisatinitialdiagnosistherapeuticapproachesandprognosticfactors |